The cumulative risks to those at age 80 are reported as being approximately 2.5% for pancreatic cancer for both BRCA1 and BRCA2 carriers, and 27% for prostate cancer for BRCA2 carriers [4]. This evidence concerns the gene BRCA2 and prostate cancer.